Warby Parker (WRBY) Asset Writedowns and Impairment (2021 - 2026)
Warby Parker's (WRBY) quarterly Asset Writedowns and Impairment came in at $468000.0 in Q1 2026, up 56.0% YoY from $300000.0 in Q1 2025, and up 917.39% on a QoQ basis from $46000.0 in Q4 2025.
Warby Parker (WRBY) Asset Writedowns and Impairment (2021 - 2026) Analysis & Trends
Warby Parker (WRBY) has 6 years of Asset Writedowns and Impairment data on file, last reported at $468000.0 in Q1 2026.
- Quarterly Asset Writedowns and Impairment rose 56.0% year-over-year to $468000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $714000.0 (changed 0.28% YoY) and the FY2025 annual result came in at $557000.0, down 31.74% from the prior year.
- Asset Writedowns and Impairment grew to $468000.0 in Q1 2026, from $46000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $1.8 million in Q4 2023 to a low of $46000.0 in Q4 2025.
- A 5-year average of $449933.3 and a median of $300000.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment soared 1903.3% — and 2024, when it slumped 87.5%.
- Tracing WRBY's Asset Writedowns and Impairment over 5 years: stood at $91000.0 in 2022, then soared by 1903.3% to $1.8 million in 2023, then tumbled by 82.67% to $316000.0 in 2024, then plunged by 85.44% to $46000.0 in 2025, then surged by 917.39% to $468000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $468000.0 (Q1 2026), $46000.0 (Q4 2025), and $200000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Warby Parker | 3.41 Bn | 3.12 Bn | 136.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 200,000.00 |
| Jun 30, 2026 | 200,000.00 |
| Mar 31, 2026 | 468,000.00 |
| Mar 31, 2026 | 468,000.00 |
| Dec 31, 2025 | 46,000.00 |
| Dec 31, 2025 | 46,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 316,000.00 |
| Dec 31, 2024 | 316,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 1.82 Mn |
| Dec 31, 2023 | 1.82 Mn |
| Sep 30, 2023 | 800,000.00 |
| Sep 30, 2023 | 800,000.00 |